Status:

TERMINATED

Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer

Lead Sponsor:

IRCCS San Raffaele

Conditions:

Pancreatic Cancer

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

RATIONALE: Drugs used in chemotherapy, such as mitomycin C and ifosfamide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Givi...

Detailed Description

OBJECTIVES: * To assess the therapeutic activity of a mitomycin C and ifosfamide combination, in terms of progression-free survival rate at 6 months, in patients with metastatic stage IV adenocarcino...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Histologically or cytologically confirmed adenocarcinoma of the pancreas
  • Stage IV disease
  • Metastatic disease
  • Prior treatment with gemcitabine-based chemotherapy, also in the adjuvant setting, with progression-free survival at ≤ 12 months
  • Measurable disease according RECIST criteria
  • No symptomatic brain metastases
  • PATIENT CHARACTERISTICS:
  • Karnofsky performance status 60-100% (80-100% in patients \> 70 years of age)
  • Adequate bone marrow, liver, and kidney function
  • Not pregnant or nursing
  • No other prior or concurrent malignancies except surgically cured carcinoma in situ of the cervix, basal cell or squamous cell carcinoma of the skin, or other neoplasms with no evidence of disease ≥ 5 years
  • No severe comorbidities that could compromise safety, including any of the following:
  • Cardiac failure
  • Cardiac arrhythmia
  • Prior myocardial infarction within the past 4 months
  • History of psychiatric disabilities
  • PRIOR CONCURRENT THERAPY:
  • See Disease Characteristics
  • No prior mitomycin C and ifosfamide
  • No concurrent treatment with experimental drugs

Exclusion

    Key Trial Info

    Start Date :

    March 1 2006

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    June 1 2008

    Estimated Enrollment :

    21 Patients enrolled

    Trial Details

    Trial ID

    NCT00967291

    Start Date

    March 1 2006

    End Date

    June 1 2008

    Last Update

    February 1 2012

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Istituto Scientifico H. San Raffaele

    Milan, Italy, 20132

    Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer | DecenTrialz